LianBio Receivables

The latest receivables for LIAN is $40M as of December 2023. That compares with $1.8M in the prior-year period — up 2154.9% year over year. Investors often review this figure alongside LianBio's historical trend and sector peers before judging valuation or financial health.

Over the past year, LIAN's receivables moved from $1.8M to $40M — a 2154.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LianBio's operating scale or balance-sheet position.

A receivables figure of $40M for LIAN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LIAN's receivables ($40M), review year-over-year change from $1.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.